Maxion Therapeutics Limited
Company Profile
live
MicroMaxion Therapeutics Limited
12560803•Private Limited With Share Capital
C/O Mishcon De Reya,, Africa House, London, WC2B6AH
Get Full Access
Incorporated
16/04/2020
Company Age
6 years
Directors
11
Employees
39
SIC Code
72190
Risk
very low risk
Company Overview
Registration, classification & business activity
Maxion Therapeutics Limited (12560803) is a private limited with share capital incorporated on 16/04/2020 (6 years old) and registered in london, WC2B6AH. The company operates under SIC code 72190 and is classified as Micro.
Maxion uses its innovative knotbody technology in combination with in vitro display technologies to generate therapeutic candidates against ion channels and gpcr proteins.
Private Limited With Share Capital
SIC: 72190
Micro
Incorporated 16/04/2020
WC2B6AH
39 employees
Financial Overview
Total Assets
£53.78M
Liabilities
£2.84M
Net Assets
£50.95M
Cash
£48.52M
Key Metrics
39
Employees
11
Directors
32
Shareholders
1
Patents
Board of Directors
5
Name
Position
director
director
director
director
director
Filed Documents
66
Document Name
Category
Date
Accounts With Accounts Type Small
Category:Accounts
Date:02-04-2026
Capital Allotment Shares
Category:Capital
Date:23-03-2026
Appoint Person Director Company With Name Date
Category:Officers
Date:23-09-2025
Accounts With Accounts Type Small
Category:Accounts
Date:23-07-2025
Notification Of A Person With Significant Control Statement
Category:Persons With Significant Control
Date:03-07-2025
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:03-07-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:22-05-2025
Capital Allotment Shares
Category:Capital
Date:09-04-2025
Capital Name Of Class Of Shares
Category:Capital
Date:08-04-2025
Resolution
Category:Resolution
Date:01-04-2025
Memorandum Articles
Category:Incorporation
Date:01-04-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:26-03-2025
Appoint Person Director Company With Name Date
Category:Officers
Date:26-03-2025
Termination Director Company With Name Termination Date
Category:Officers
Date:26-03-2025
Capital Allotment Shares
Category:Capital
Date:20-01-2025
Capital Allotment Shares
Category:Capital
Date:26-11-2024
Resolution
Category:Resolution
Date:06-08-2024
Capital Allotment Shares
Category:Capital
Date:01-08-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:19-06-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:10-05-2024
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:04-04-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:18-03-2024
Resolution
Category:Resolution
Date:18-03-2024
Memorandum Articles
Category:Incorporation
Date:18-03-2024
Capital Allotment Shares
Category:Capital
Date:13-03-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-12-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:27-09-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:08-09-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:03-05-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:28-04-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:28-04-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:27-04-2023
Change Person Director Company With Change Date
Category:Officers
Date:27-04-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:08-02-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:08-02-2023
Memorandum Articles
Category:Incorporation
Date:08-02-2023
Resolution
Category:Resolution
Date:08-02-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:07-02-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:07-02-2023
Capital Allotment Shares
Category:Capital
Date:07-02-2023
Capital Name Of Class Of Shares
Category:Capital
Date:07-02-2023
Capital Allotment Shares
Category:Capital
Date:03-02-2023
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:03-02-2023
Termination Secretary Company With Name Termination Date
Category:Officers
Date:03-02-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:03-02-2023
Change Person Director Company With Change Date
Category:Officers
Date:19-12-2022
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:19-12-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:29-07-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:28-04-2022
Memorandum Articles
Category:Incorporation
Date:25-04-2022
Resolution
Category:Resolution
Date:25-04-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:21-04-2022
Capital Allotment Shares
Category:Capital
Date:20-04-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:20-04-2022
Appoint Person Director Company With Name Date
Category:Officers
Date:20-04-2022
Resolution
Category:Resolution
Date:04-09-2021
Resolution
Category:Resolution
Date:04-09-2021
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:06-08-2021
Confirmation Statement With Updates
Category:Confirmation Statement
Date:16-04-2021
Capital Alter Shares Subdivision
Category:Capital
Date:21-01-2021
Resolution
Category:Resolution
Date:21-01-2021
Memorandum Articles
Category:Incorporation
Date:21-01-2021
Capital Variation Of Rights Attached To Shares
Category:Capital
Date:21-01-2021
Capital Name Of Class Of Shares
Category:Capital
Date:21-01-2021
Change Account Reference Date Company Current Shortened
Category:Accounts
Date:16-06-2020
Incorporation Company
Category:Incorporation
Date:16-04-2020
Innovate Grants
2
This company received a grant of £1948356.0 for Development Of A Novel Class Of Ion Channel Blockers For The Treatment Of Autoimmune Disease. The project started on 01/04/2023 and ended on 31/03/2026.
This company received a grant of £349947.5 for An Innovative Molecular Fusion Format That Targets Ion Channel-Driven Diseases. The project started on 01/05/2021 and ended on 31/10/2022.
Import / Export
Imports
12 Months10
60 Months38
Exports
12 Months0
60 Months6
Risk Assessment
very low risk
International Score
Future Factor
good
Performance Rating
Accounts
Typesmall company
Due Date30/09/2027
Filing Date02/04/2026
Latest Accounts31/12/2025
Trading Addresses
C/O Mishcon De Reya,, Africa House, London, Wc2B 6Ah, WC2B6AHRegistered
Related Companies
10
Contact
03031231113info@maxion.co.ukmaxiontherapeutics.com
C/O Mishcon De Reya,, Africa House, London, WC2B6AH